TD2 Oncology
This role involves independently managing clinical trial research sites to ensure oncology trials are completed in compliance with protocols, GCP, FDA regulations, and ICH guidelines. The position requires overseeing all aspects of Phase I-III trials, from clinical start-up through close-out activities, while maintaining efficient working relationships with investigators and site staff. The role focuses on protecting subject welfare and ensuring proper trial oversight.
Headquarters
Scottsdale, Arizona, United States
Company Size
51-200 employees
Founded
2003
TD2 Oncology is a leading oncology contract research organization (CRO) that advances cancer research by guiding new therapies from preclinical stages through clinical trials to FDA approval. As a partner to biotech and pharmaceutical companies, it provides end-to-end CRO services across study design, trial execution, data management, and regulatory support. The company emphasizes speed, quality, and regulatory alignment to accelerate oncology programs toward market. With a focus on collaboration and scientific rigor, TD2 Oncology helps bring new cancer therapies to patients faster.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for TD2 Oncology.
TD2 Oncology didn’t post a salary, so this is our estimate from similar listings.
36% below the average for this role